Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

The duration of analgesia from brachial plexus block was not significantly affected by timing of intravenous dexamethasone administration. The timing of intravenous (IV) dexamethasone ...

The usual but empirical initial dose in brain tumor patients is an intravenous bolus of 10 mg of dexamethasone, followed by a maintenance dose of 4 mg given by the intravenous (IV) route every 6 ...